日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction

纽约心脏协会心功能分级与射血分数降低的心力衰竭患者报告结局的比较

Greene, Stephen J; Butler, Javed; Spertus, John A; Hellkamp, Anne S; Vaduganathan, Muthiah; DeVore, Adam D; Albert, Nancy M; Duffy, Carol I; Patterson, J Herbert; Thomas, Laine; Williams, Fredonia B; Hernandez, Adrian F; Fonarow, Gregg C

Heterogeneity of health status treatment response with sacubitril/valsartan: insights from the CHAMP-HF registry

沙库巴曲/缬沙坦治疗对健康状况反应的异质性:来自 CHAMP-HF 注册研究的启示

Khariton, Yevgeniy; Fonarow, Gregg C; Hellkamp, Ann; Thomas, Laine; Nassif, Michael E; Butler, Javed; Duffy, Carol I; Albert, Nancy M; Spertus, John A

Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial

急性失代偿性心力衰竭后启动血管紧张素-脑啡肽酶抑制剂治疗:PIONEER-HF试验开放标签扩展研究的二次分析

DeVore, Adam D; Braunwald, Eugene; Morrow, David A; Duffy, Carol I; Ambrosy, Andrew P; Chakraborty, Hrishikesh; McCague, Kevin; Rocha, Ricardo; Velazquez, Eric J

Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial

PIONEER-HF试验中不同剂量水平下沙库巴曲/缬沙坦的疗效和安全性

Berg, David D; Braunwald, Eugene; DeVore, Adam D; Lala, Anuradha; Pinney, Sean P; Duffy, Carol I; Gurmu, Yared; Velazquez, Eric J; Morrow, David A

Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial.

在 PIONEER-HF 试验中,将急性失代偿性心力衰竭患者随机分配至沙库巴曲缬沙坦组或依那普利组,并检测其心血管生物标志物

Morrow David A, Velazquez Eric J, DeVore Adam D, Prescott Margaret F, Duffy Carol I, Gurmu Yared, McCague Kevin, Rocha Ricardo, Braunwald Eugene

Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry

心力衰竭药物治疗和血压的目标剂量:来自 CHAMP-HF 注册研究的启示

Peri-Okonny, Poghni A; Mi, Xiaojuan; Khariton, Yevgeniy; Patel, Krishna K; Thomas, Laine; Fonarow, Gregg C; Sharma, Puza P; Duffy, Carol I; Albert, Nancy M; Butler, Javed; Hernandez, Adrian F; McCague, Kevin; Williams, Fredonia B; DeVore, Adam D; Patterson, J Herbert; Spertus, John A

Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction

沙库巴曲/缬沙坦治疗与射血分数降低的心力衰竭患者健康状况结局之间的关联

Khariton, Yevgeniy; Fonarow, Gregg C; Arnold, Suzanne V; Hellkamp, Ann; Nassif, Michael E; Sharma, Puza P; Butler, Javed; Thomas, Laine; Duffy, Carol I; DeVore, Adam D; Albert, Nancy M; Patterson, J Herbert; Williams, Fredonia B; McCague, Kevin; Spertus, John A

Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF

心力衰竭治疗方案改变与患者健康状况的关联:来自 CHAMP-HF 研究的真实世界证据

Thomas, Merrill; Khariton, Yevgeniy; Fonarow, Gregg C; Arnold, Suzanne V; Hill, Larry; Nassif, Michael E; Sharma, Puza P; Butler, Javed; Thomas, Laine; Duffy, Carol I; DeVore, Adam D; Hernandez, Adrian; Albert, Nancy M; Patterson, J Herbert; Williams, Fredonia B; McCague, Kevin; Spertus, John A

Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry

门诊心力衰竭患者健康状况在不同医疗机构间的差异:来自 CHAMP-HF(改变心力衰竭患者管理)注册研究的启示

Khariton, Yevgeniy; Hernandez, Adrian F; Fonarow, Gregg C; Sharma, Puza P; Duffy, Carol I; Thomas, Laine; Mi, Xiaojuan; Albert, Nancy M; Butler, Javed; McCague, Kevin; Nassif, Michael E; Williams, Fredonia B; DeVore, Adam; Patterson, J Herbert; Spertus, John A

Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF Trial

CHAMP-HF 注册研究入组患者的特征和治疗与 PARADIGM-HF 试验入组患者的比较

DeVore, Adam D; Mi, Xiaojuan; Thomas, Laine; Sharma, Puza P; Albert, Nancy M; Butler, Javed; Hernandez, Adrian F; Patterson, J Herbert; Spertus, John A; Williams, Fredonia B; Duffy, Carol I; McCague, Kevin; Fonarow, Gregg C